Katherine A Morgan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Cognitive Decline

Simultaneous Determination

Oxide Nanoparticles

Top Venues

Chemical communications (Cambridge, England)

Chemical science

This page only lists publications with an associated author ORCID identifier.

Publications

Katherine A Morgan, Christian Werner Wichmann, Laura D Osellame, Zhipeng Cao, Nancy Guo, Andrew Mark Scott, Paul S Donnelly
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX. Chemical science 15 (9) (2024)
Katherine A Morgan, Christian Werner Wichmann, Laura D Osellame, Zhipeng Cao, Nancy Guo, Andrew Mark Scott, Paul S Donnelly
Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX. Chemical science 15 (9) (2024)
Katherine A Morgan, Michael de Veer, Luke A Miles, Cormac A A Kelderman, Catriona A McLean, Colin L Masters, Kevin J Barnham, Jonathan M White, Brett M Paterson, Paul S Donnelly
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease. Chemical communications (Cambridge, England) 59 (16) (2023)
Katherine A Morgan, Michael de Veer, Luke A Miles, Cormac A A Kelderman, Catriona A McLean, Colin L Masters, Kevin J Barnham, Jonathan M White, Brett M Paterson, Paul S Donnelly
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease. Chemical communications (Cambridge, England) (2023)
Katherine A Morgan, Michael de Veer, Luke A Miles, Cormac A A Kelderman, Catriona A McLean, Colin L Masters, Kevin J Barnham, Jonathan M White, Brett M Paterson, Paul S Donnelly
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease. Chemical communications (Cambridge, England) 59 (16) (2023)
Katherine A Morgan, Michael de Veer, Luke A Miles, Cormac A A Kelderman, Catriona A McLean, Colin L Masters, Kevin J Barnham, Jonathan M White, Brett M Paterson, Paul S Donnelly
Pre-targeting amyloid-β with antibodies for potential molecular imaging of Alzheimer's disease. Chemical communications (Cambridge, England) 59 (16) (2023)